1 study on Acth curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently curates 1 dated study on Acth. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.
**The assumed requirement for cyclic AMP in KPV and alpha-MSH anti-inflammatory action must be reconsidered** — at least in keratinocytes, the operative second messenger appears to be intracellular calcium, not cAMP. …
Free, no account — handy when you're working with Acth.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account